Now a part of Servier Group. Focused on developing better, targeted medicines faster for patients of all ages who need new options.dayonebio.com South San Francisco, CAJoined November 2018
We’re bringing the #Servier mission to life at #ASCO26!
We asked a few members of our team to share what they’re most excited about at this year’s meeting.
Hear directly from employees as they reflect on the science, collaboration, and progress shaping the future of oncology.
New data on our investigational medicine for adenoid cystic carcinoma (ACC) at #ASCO26! These new insights in the ACC population will be presented during an oral session today highlighting an encouraging profile with early anti-tumor activity. More details in today’s release here: bit.ly/43KhjLC
#ASCO26 is underway, and we're excited to be part of the conversation shaping the future of oncology care. Stop by booths #36155 and #12079 to connect with our teams and learn about our ongoing work to advance cancer research and treatment.
We’re excited to be here at #ASCO26!
Come visit booth #12079 & #36155 to connect with our team and discover how we’re driving progress across a range of rare cancers, including IDH-mutated glioma and adenoid cystic carcinoma (ACC).
Learn more: lnkd.in/eDqc5YVr
We're excited to join the oncology research and care community at #ASCO26 next week!
Our team will be presenting new data for our investigational medicine for patients with the adenoid cystic carcinoma (ACC) during an oral presentation on June 1. Learn more here: bit.ly/4v1a3GX
Heading to #ASCO26? Visit us at booth #36155.
Today we've announced the completed enrollment in the FIREFLY-2 clinical trial, evaluating our medicine as a front-line treatment for pediatric low-grade glioma (pLGG). This is another step forward in our work to evolve the pLGG treatment paradigm and ultimately establish a new standard of care for patients newly diagnosed with pLGG. Read more: bit.ly/4uvVPgV
Today we’ve announced a definitive agreement to be acquired by @Servier. Servier shares our deep commitment to advancing innovation in cancer along with our patient-focused methodology to address the most pressing areas of unmet need. Please refer to today’s press release for important information about this transaction. ir.dayonebio.com/news-releases/…
Day One announces preliminary 2025 OJEMDA Net Product Revenue and provides 2026 Revenue Guidance ahead of CEO Jeremy Bender's presentation at #JPM26 today at 5:15 pm PT. Read the press release here: bit.ly/45FFCvH
Today we've completed the acquisition of Mersana Therapeutics, expanding our pipeline with a clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting adenoid cystic carcinoma (ACC).
This program is well aligned to our mission to develop innovative medicines for patients who urgently need them and broadens our opportunity for patient impact and continued growth.
Read the press release here: bit.ly/4qAuPLf
Day One announces our three-year results from the Phase 2 FIREFLY-1 trial, presented in an oral presentation at the Society for Neuro-Oncology (SNO) Annual Meeting #SNO2025. Learn more here: bit.ly/47ZlMNJ
Join Dr. Cassie Kline on Sunday, November 23 at the Society of Neuro-Oncology (SNO) Annual Meeting to hear the three-year follow-up data from the Phase 2 FIREFLY-1 trial.
#SNO2025
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases. Read more: bit.ly/4qW6Qr5
We’re thrilled to announce that Michael Vasconcelles, M.D., has joined Day One as Head of Research & Development (R&D). Mike brings more than 25 years of experience in oncology research and development as an academic hematologist/oncologist and as an industry leader in large pharmaceutical, health technology, and emerging biotechnology companies.
Mike will be instrumental in helping to drive innovative medical and scientific strategies to support OJEMDA’s growth while also continuing to build our pipeline of first- or best-in-class medicines for patients of all ages with life-threatening diseases.
Read more: bit.ly/3Zq67Cj
Day One will be participating in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami on Tuesday, June 10th. Learn more about our pipeline and commitment to developing and commercializing targeted therapies for people of all ages living with life-threatening diseases.
View the webcast here: bit.ly/43R1Fhv
We're gearing up for this year's @ASCO Annual Meeting and we're excited to see everyone in Chicago! #ASCO25 abstracts include data from the FIREFLY-1 study in pediatric low-grade glioma (pLGG):
📌Abstract 10029 on growth recovery in patients with BRAF-altered pLGG after discontinuing tovorafenib
📌Abstract 10037 on a post hoc analysis of rashes reported in relapsed/refractory pLGG patients treated with tovorafenib
If you're attending, stop by booth 34149 to meet the Day One team and learn more about how we're bringing novel targeted therapies to children and adults with cancer.
The Day One team is excited to be at the 2025 @ASPHO_hq Conference in Louisville this week! Stop by our booth 113 to hear how we're redefining what's possible for people of all ages living with cancer. #ASPHO2025
Learn more about our mission here: bit.ly/4gsrd8W
3K Followers 2K FollowingPediatric oncologist. Cancer drug developer.
Founder and former Head of R & D @DayOneBio.
Now tweeting at @drsam.bsky.social (instead of this hellsite) #resist
128K Followers 799 FollowingBiotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
56K Followers 736 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
4K Followers 611 Followingpediatric neurooncologist and physician scientist, passionate about finding new treatments for pediatric brain cancer @dfbc_pedcare @danafarber @bostonchildrens
25K Followers 766 FollowingScientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
5K Followers 417 FollowingFormer CEO @NimbusTx. Board member at multiple companies helping teams discover & develop new medicines for patients. Any tweets are solely my own views.
11K Followers 471 FollowingA multidisciplinary society of healthcare professionals dedicated to promoting advances in neuro-oncology through research and education.
3K Followers 2K Followingprofessor of paedatric heamatology/oncology research | #CSRG | #DunLab | husband, dad | seahorse, wildfire, cockatoo | lover of surf, guitar, family and friends
388K Followers 12K FollowingCNN senior politics reporter Co-founder @TeamBeansFund - funding childhood cancer research in memory of my daughter. Signal: Akzn.24
33K Followers 285 FollowingJournalist @ApexOnco. The Wolverine Of Biotech / Mr ASH. Never paid for a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
2K Followers 5K FollowingA GuideStar platinum rated registered 501(c)3, leading the fundraising efforts for PNOC's pediatric brain cancer research and clinical trials.
3K Followers 1K FollowingFounder/CEO, @1ABMedia. Brand builder & C-suite advisor for biotechs and VCs. Secretary/Director, LJ Piniella Foundation. Jersey guy/NY sports fan living in FL
4K Followers 1K FollowingThe Pediatric Brain Tumor Foundation leads the way in funding research, supporting families and advocating for policies to end childhood brain cancer.
3K Followers 2K FollowingFounder & Managing Partner of 5AM Ventures. Med school drop-out and former biotech I-banker with a passion for entrepreneurship. Cincy, SF & Davidson fan...
434 Followers 215 FollowingTranslational neuro-oncologist @hopkinskimmel
focused on the exploitation of targetable genomic driver mutations in gliomas, particularly BRAF.
5K Followers 3K FollowingNonprofit organization harnessing the power of sport to build a community that invests in the lives of people impacted by rare diseases.
2K Followers 2K FollowingWe are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
2K Followers 523 FollowingDeputy Editor @NatureMedicine | Handling research in #oncology #immunology #immunotherapy | Follow me on Bluesky! @sahelisadanand.bsky.social
223 Followers 72 FollowingDedicated to accelerating the clinical development of therapies to treat glioblastoma. For more details, visit https://t.co/KccGQYDWHT.
3K Followers 2K FollowingKind legends only. Canary Cure Therapeutics 🧬metabolic restoration. My name means unlimited happiness and my blood type is Be Positive 🙂🎾 MIA🌴My tweets.
28K Followers 2K FollowingTeam Jack Foundation has raised millions of dollars for impactful child brain cancer research and works to create national awareness for the disease.
1K Followers 517 FollowingNonprofit speeding the pace of cancer research. We collaborate. We save #bigdata. We #RunDisney. #curesnotcredit #btsm #Cavatica #braincancer #childhoodcancer
106K Followers 6K FollowingI Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech
12K Followers 6K FollowingCalifornia Life Sciences is the state’s most impactful life sciences membership org. advocating for the industry & its diverse innovation pipeline
157 Followers 118 FollowingThe Lilabean Foundation for Pediatric Brain Cancer Research (LBF) seeks to fund critical childhood brain cancer research and help raise awareness of the severit
89 Followers 147 FollowingThis summit brings experts in pediatric neuro-oncology & opportunities to learn more about the #1 disease-related killer in children: Brain Cancer!
122 Followers 224 FollowingCurrent post-doc @LawlorLab at Seattle Children’s Research Institute. I study the tumor micro environment and metastatic potential of Ewing Sarcoma.
4K Followers 1K FollowingPhysician/investigator/educator/academic and industrial collaborator. Prof, @Dana-Farber and Ludwig Center @Harvard Medical School.All tweets my personal views.
3K Followers 807 FollowingCSO Parker Institute for Cancer Immunotherapy @parkerici, Dir Prog in Translational Immunology IMCB A*Star, Adj Prof @Baylor University; all views are my own.
4K Followers 4K FollowingThe largest patient support NGO for childhood cancer. Global, parent-driven, recognized world-wide as the voice for children with cancer, families and survivors
7K Followers 865 FollowingACCO is the oldest & largest grassroots childhood cancer organization in the U.S. dedicated to making childhood cancer a national priority 🎗 #ACCO #GoGold®
5K Followers 3K FollowingLargest #Phase0 clinical trials program in the world providing personalized treatment options for patients with #glioblastoma & other aggressive brain tumors.
819 Followers 694 FollowingSince 2001, Meagan Bebenek Foundation has been dedicated to raise awareness and provide support to children and families affected by brain tumors.
3K Followers 2K FollowingConnecting and supporting families in Iowa affected by childhood cancer
COCA-I Gold Ribbon Camp
https://t.co/7f9lJogh3Q
#ccc #nonprofit
132 Followers 237 Following"I alone can not change the world, but I can cast a stone across the waters to create many ripples" #fightlikeakid #gogold #childhoodcancer #life #eyesopened
120 Followers 746 FollowingHusband, Dad, Meghan K Duffy Memorial Foundation and DFCI Jimmy Fund - Fundraiser. Providence College Lax Alum, PMC Rider, Red Sox and PC Friars Fan
481 Followers 400 FollowingThe Noonan Syndrome Foundation is the leading non-profit organization whose mission is to support, educate, and advocate for those with Noonan syndrome.